The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL ...

(WASHINGTON) — The U.S. Food and Drug Administration (FDA) approved on Friday additional ... artificial food dyes. The agency approved two dyes and expanded approval of a third, meaning it ...